Skip to content

Decision-making during a routine follow-up visit 10 years after a total hip or knee arthroplasty

Decision-making of the orthopedic surgeon during a routine follow-up visit of patients 10 years after a total hip or knee arthroplasty - Decision-making 10 years FU

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58213
Enrollment
50
Registered
2025-12-09
Start date
2025-12-15
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

total knee arthroplasty, total hip arthroplasty total knee prosthesis, total hip prosthesis

Interventions

Patients will have a routine follow-up &nbsp
10 years after THA or TKA consisting of a clinical visit and X-ray

Sponsors

Reinier Haga Orthopedisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: underwent a total knee or total hip arthroplasty (TKA or THA) approximately 10 years agoAge 50 years or older at time of TKA or THAGiven written informed consent for the HAKA II trial to use their data for further research 

Exclusion criteria

Exclusion criteria: Other indication for surgery than osteoarthritisSurgery was bilateralDeceasedRevision arthroplasty of hip or knee

Design outcomes

Primary

MeasureTime frame
Factors which have a role during the decision-making of the orthopedic surgeon, like anamnesis, physical examination, X-rays, medical history, patient preferences and clinical intuition. The strength of the influence of these factors will be registered on a scale from 0 to 4. The same outcomes will be registered during the case-vignette study. 

Secondary

MeasureTime frame
To get more insight in the cases, also the complaints and abnormalities on the X-rays will be registered. 

Countries

Netherlands

Contacts

Public ContactJ.H. Pasma

Reinier Haga Orthopedisch Centrum

onderzoek@rhoc.nl079-2065595

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)